Concepedia

Anna Josephine Gebhardt

AJ

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2022

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

Universität Hamburg

Anna Josephine Gebhardt is an author at University Medical Center Hamburg-Eppendorf specializing in antibody specificity engineering, biologic therapies, and multiple myeloma therapy.

ORCID

Publications per year

2022–2024

3

Publications

3

Half-Life Extended Nanobody-Based CD38-Specific Bispecific Killercell Engagers Induce Killing of Multiple Myeloma Cells

Julia Hambach, William Fumey, Tobias Stähler et al. · Frontiers in Immunology · 2022 · 24 citations · Full text

, , +17

Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire

Thomas Watts Eden, Alessa Z. Schaffrath, Janusz Wesolowski et al. · Nature Communications · 2024 · 19 citations · Full text

, , +17

CD38-specific nanobodies allow in vivo imaging of multiple myeloma under daratumumab therapy

Luca Julius Pape, Julia Hambach, Anna Josephine Gebhardt et al. · Frontiers in Immunology · 2022 · 14 citations · Full text

, , +17

1–3 of 3